Article Details
Retrieved on: 2022-05-31 16:16:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Enter tegoprubart, an investigational humanized monoclonal antibody that inhibits CD40L. Eledon's 12-week trial studying 54 patients demonstrated ...
Article found on: www.pharmalive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here